Cardiac Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
Description
Cardiac Monitoring Devices Market Summary
This cardiac monitoring devices market report offers a comprehensive overview of the global cardiac monitoring devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (ECG Devices {Holter Monitors, Resting ECG, and Stress ECG}, Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-Users (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cardiac monitoring devices market.
Cardiac monitoring devices are medical devices used to continuously or intermittently measure and record the electrical activity and overall function of the heart. These devices help detect, diagnose, and manage heart-related conditions such as arrhythmias, heart failure, myocardial infarction, and other cardiovascular disorders.
The cardiac monitoring devices market is primarily driven by the increasing prevalence of cardiovascular diseases and associated risk factors such as hypertension, obesity, and diabetes. Additionally, the growing demand for remote patient monitoring solutions, especially with the rise of home-based care and telehealth services, is significantly supporting market growth. Furthermore, continuous technological advancements and increased product development initiatives by key market players are enhancing device accuracy, portability, and connectivity, thereby accelerating overall market expansion.
Get More Insights into the Report @Cardiac Monitoring Devices Market
What are the latest cardiac monitoring devices market dynamics and trends?
The cardiac monitoring devices market is experiencing significant growth, primarily fueled by the increasing incidence of cardiovascular diseases (CVDs), including heart failure and coronary artery disease, as well as the growing burden of related risk factors.
According to the Institute for Health Metrics and Evaluation (2025), ischemic heart disease affected an estimated 240 million people in 2023 worldwide. As ischemic heart disease results from reduced blood supply to the heart caused by coronary artery narrowing, patients require continuous and long-term cardiac surveillance to detect ischemic episodes, rhythm abnormalities, and recurrent cardiac events at an early stage. This has increased the demand for advanced monitoring technologies, including ECG systems, Holter monitors, wearable ECG patches, telemetry systems, and implantable loop recorders.
Additionally, the increase in cases of associated risk factors such as hypertension, obesity, and diabetes is further boosting the overall market of cardiac monitoring devices. According to the data provided by the World Health Organization (2025), approximately 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. Obesity is significantly boosting the overall market of cardiac monitoring devices because it is a major risk factor for several cardiovascular conditions, including Coronary Artery Disease, Atrial Fibrillation, Heart Failure, and Hypertension. Excess body weight contributes to structural and electrical remodeling of the heart, increasing the likelihood of arrhythmias and ischemic events that require continuous cardiac rhythm assessment. As obesity prevalence rises globally, the number of high-risk patients needing early detection, long-term ECG tracking, and post-treatment surveillance also increases, thereby boosting the overall market of cardiac monitoring devices across the world.
Moreover, wearable and remote patient monitoring technologies are significantly accelerating growth in the cardiac monitoring devices market by enabling continuous, convenient, and real-time tracking of heart health outside hospital settings, improving early detection of arrhythmias, ischemia, and other cardiac events while reducing the need for in-person visits and supporting telehealth care delivery. This shift toward decentralized care and preventive cardiology has increased demand for smart wearables, ECG patches, mobile telemetry systems, and cloud-linked monitoring platforms that transmit data directly to clinicians for timely intervention, driving broader market adoption and innovation. Specifically, recent approvals and product launches include: in July 2025, the FDA cleared the CardioTag wearable capable of capturing ECG, photoplethysmogram (PPG), and seismocardiogram (SCG) signals, enhancing non-invasive cardiac insights.
However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For instance, in June 2024, Endotronix received U.S. FDA Premarket Approval (PMA) for its Cordella PA Sensor System, designed to manage patients with NYHA Class III heart failure. The system enables remote monitoring of pulmonary artery pressure along with non-invasive vital signs, helping clinicians optimize treatment plans and reduce the risk of hospitalizations. The company anticipated a U.S. commercial launch later in the year, while CE mark review was underway to support expansion into the European market.
Overall, the rising prevalence of cardiovascular diseases, the growing adoption of remote monitoring solutions, and continuous regulatory approvals are collectively expected to strongly propel the growth of the global cardiac monitoring devices market throughout the forecast period.
Moreover, the cardiac monitoring devices market faces several restraints and challenges. One major concern is data privacy and security, as these devices collect and store sensitive patient health information, which can be vulnerable to cyberattacks and data breaches. Additionally, limitations associated with the devices, such as high costs, limited battery life, technical errors, and the need for regular maintenance, can restrict their widespread adoption. Furthermore, issues related to device accuracy, connectivity problems, and a lack of skilled professionals to interpret complex data may also hinder market growth.
Cardiac Monitoring Devices Market Segment Analysis
Cardiac Monitoring Devices Market by Product Type (ECG Devices {Holter Monitors, Resting ECG, and Stress ECG}, Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-Users (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Cardiac Monitoring Devices Market Regional Analysis
North America Cardiac Monitoring Devices Market Trends
North America is expected to account for the highest proportion of 41% of the cardiac monitoring devices market in 2025, out of all regions. North America is expected to hold the largest share of the global cardiac monitoring devices market, primarily supported by the high incidence of cardiovascular diseases, a growing geriatric population, and the early adoption of advanced technologies, including AI-enabled wearables and remote patient monitoring systems. The region benefits from a well-established healthcare infrastructure, favorable reimbursement policies, and consistent FDA approvals for innovative cardiac devices, all of which strengthen its market dominance. Furthermore, the strong presence of leading industry players and an increasing focus on preventive and value-based healthcare continue to drive sustained market growth across the region.
According to the Centers for Disease Control and Prevention (2024), it was estimated that approximately 12.1 million people in the United States would have atrial fibrillation (AFib) by 2050. Additionally, according to DelveInsight’s 2024 analysis, an estimated 5.0% of adults in the United States had coronary heart disease. Both conditions are significant contributors to heart failure and other serious complications, highlighting the urgent need for effective cardiac monitoring solutions that support early diagnosis, better disease management, and improved survival rates.
Additionally, awareness campaigns such as American Heart Month, spearheaded by organizations like the American Heart Association (AHA) and the CDC, play an important role in encouraging prevention, routine screenings, and continuous heart health monitoring. These initiatives, combined with ongoing product innovations, are further accelerating the adoption of advanced cardiac monitoring devices.
However, the increase in product development activities is further boosting the overall market ofcardiac monitoring devices. For example, in November 2024, Fourth Frontier received U.S. FDA 510(k) clearance for its Frontier X Plus, a single-lead continuous ECG monitor designed to be worn around the chest. The device wirelessly transmits ECG data to remote monitoring dashboards and uses advanced algorithms to detect and classify cardiac rhythms, including bradycardia, tachycardia, normal sinus rhythm, and atrial fibrillation.
Overall, the substantial burden of cardiovascular diseases, rapid adoption of advanced technologies, growing patient awareness, and a consistent flow of regulatory approvals are collectively expected to support the sustained growth of the cardiac monitoring devices market across North America.
Thus, all the above-mentioned factors are anticipated to propel the market for cardiac monitoring devices in North America during the forecast period.
Europe Cardiac Monitoring Devices Market Trends
Europe is contributing significantly to the expansion of the cardiac monitoring devices market, supported by the increasing prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and favorable regulatory and reimbursement policies.
According to DelveInsight’s 2023 analysis of the EU4 and the UK, the prevalence of diagnosed atherosclerotic cardiovascular disease (ASCVD) was notably higher in males, with approximately 12,601 thousand cases, compared to around 8,645 thousand cases in females. Men generally develop ASCVD at an earlier age and face a greater risk of coronary heart disease (CHD) than women. This substantial burden of heart and circulatory disorders has significantly increased the demand for advanced diagnostic and monitoring technologies, including Holter monitors, implantable loop recorders, telemetry systems, and wearable ECG devices.
Furthermore, healthcare providers across Europe are progressively adopting remote patient monitoring and digital health solutions, supported by initiatives aimed at strengthening telemedicine services and reducing hospital readmissions. However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For example, in January 2024, iRhythm Technologies received CE Mark certification under the new EU Medical Device Regulation (MDR) for its next-generation Zio ECG monitoring system and the ZEUS AI-powered ECG analysis platform, marking a key milestone in ambulatory cardiac monitoring innovation. With increasing investments in AI-enabled monitoring systems, wearable technologies, and cross-border healthcare advancements, Europe continues to play a critical role in driving the growth and evolution of the cardiac monitoring devices market.
Hence, all the factors mentioned above are expected to drive the market for cardiac monitoring devices in Europe during the forecast period.
Asia-Pacific Cardiac Monitoring Devices Market Trends
The Asia-Pacific region is increasingly becoming a key growth engine for the cardiac monitoring devices market, supported by the rising incidence of cardiovascular diseases, a rapidly expanding elderly population, and the growing adoption of digital healthcare technologies. Major countries such as China, India, and Japan are witnessing a significant increase in heart-related disorders, largely driven by lifestyle changes, rapid urbanization, and the escalating prevalence of risk factors including diabetes, obesity, and hypertension.
According to an article published in the European Heart Journal in 2025, cardiovascular diseases affected approximately 341.6 million people across the Asia-Pacific region, with a 95% uncertainty interval (UI) ranging from 301.9 million to 329.1 million. The increasing prevalence of cardiovascular diseases (CVDs) is a major factor driving the growth of the cardiac monitoring devices market. As conditions such as coronary artery disease, heart failure, atrial fibrillation, and hypertension become more widespread, the need for continuous and accurate heart monitoring has grown significantly. Since many heart disorders require early detection and long-term management to prevent serious complications, demand for devices such as ECG systems, Holter monitors, implantable loop recorders, and wearable monitors continues to rise. Overall, the growing global burden of CVDs is strongly accelerating the adoption and development of advanced cardiac monitoring technologies.
Governments and healthcare providers across the region are making substantial investments in upgrading healthcare infrastructure and expanding remote patient monitoring programs to enhance access to cardiac care, particularly in rural and underserved areas. At the same time, the growing adoption of wearable and portable cardiac monitoring devices, along with the strategic expansion efforts of global companies into emerging Asian markets, is further supporting regional market growth.
However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For example, in May 2025, iRhythm Technologies introduced its Zio® long-term continuous ECG monitoring (LTCM) system in Japan. The system offers up to 14 days of uninterrupted ECG monitoring and incorporates deep-learning AI algorithms approved by Japan’s PMDA, representing a significant advancement over traditional Holter monitoring solutions.
Thus, the factors mentioned above are expected to boost the market of cardiac monitoring devices across the Asia-Pacific region.
Who are the major players in the cardiac monitoring devices market?
The following are the leading companies in the cardiac monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.
The competitive landscape of the cardiac monitoring devices market is becoming increasingly dynamic and innovation-driven. Leading medical device companies are focusing heavily on technological advancements such as wireless connectivity, artificial intelligence (AI)–based arrhythmia detection, cloud integration, and wearable monitoring solutions to strengthen their market position. Continuous product development and frequent product launches are enabling companies to offer more accurate, portable, and patient-friendly devices, which is intensifying competition across both hospital and home-care segments. In addition, strategic partnerships, mergers and acquisitions, and collaborations with digital health and telemedicine providers are reshaping the market structure. Established players are expanding their product portfolios, while emerging companies and startups are entering the market with innovative wearable and remote monitoring technologies. The growing demand for remote patient monitoring and long-term cardiac care has further accelerated competition, pushing companies to differentiate themselves through improved data analytics, longer monitoring durations, and better user experience. Overall, the market is characterized by strong competition, rapid technological evolution, and increasing investment in research and development, all of which are contributing to continuous innovation and market growth.
Recent Developmental Activities in the Cardiac Monitoring Devices Market
Event Recorders
Echocardiogram
Mobile Cardiac Telemetry
Others
Ambulatory Surgical Centers
Homecare Settings
Others
AI-Powered Innovations and Applications:
Artificial intelligence (AI) is significantly transforming the cardiac monitoring devices market by improving diagnostic accuracy, enhancing efficiency, and enabling more proactive patient care. AI-powered algorithms can analyze large volumes of electrocardiogram (ECG) data in real time, allowing faster and more precise detection of arrhythmias, atrial fibrillation, heart failure risk, and other cardiac abnormalities. This reduces the likelihood of missed diagnoses and supports clinicians in making timely, data-driven treatment decisions. One of the major impacts of AI integration is the improvement in early detection and predictive analytics. Advanced machine learning models can identify subtle patterns in heart rhythm data that may not be easily recognized by traditional monitoring methods. This enables earlier intervention, reduces hospital readmissions, and improves long-term patient outcomes. Additionally, AI enhances remote patient monitoring by automatically filtering and prioritizing clinically significant events, reducing the burden on healthcare professionals and minimizing false alarms. AI-powered cardiac monitoring devices also contribute to operational efficiency within healthcare systems. Automated data interpretation shortens analysis time, streamlines workflow, and allows cardiologists to focus on critical cases. In wearable and ambulatory monitoring devices, AI supports continuous data tracking and real-time alerts, improving patient engagement and enabling personalized care management.
U.S. Tariff Impact Analysis on Cardiac Monitoring Devices Market:
U.S. tariffs on imported electronic components and medical device parts have had a moderate impact on the cardiac monitoring devices market. Since many cardiac monitoring systems, such as ECG machines, Holter monitors, and wearable cardiac patches, rely on imported semiconductors, sensors, and other electronic components, increased tariffs can raise manufacturing and procurement costs. This may lead to higher device prices for hospitals and healthcare providers.
In response, manufacturers are adjusting their supply chains by diversifying sourcing strategies, increasing domestic production, or negotiating long-term supplier contracts to reduce cost pressures. While large established companies are better positioned to absorb these added costs, smaller manufacturers may face tighter margins. Overall, tariffs have contributed to pricing and supply chain challenges but have also encouraged supply chain resilience and local manufacturing investments within the U.S. market.
How This Analysis Helps Clients
- The global cardiac monitoring devices market is expected to increase from USD 22,319.66 million in 2025 to USD 34,948.16 million by 2034, reflecting strong and sustained growth.
- The global cardiac monitoring devices market is growing at a CAGR of 5.17% during the forecast period from 2026 to 2034.
- The cardiac monitoring devices market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs) such as heart failure, arrhythmias, and coronary artery disease, along with rising risk factors including hypertension, diabetes, obesity, and sedentary lifestyles. As the global burden of heart-related conditions continues to grow, the need for early diagnosis and continuous monitoring has significantly increased. Additionally, the growing demand for remote patient monitoring (RPM) is accelerating market growth. With the shift toward home-based care and telehealth services, patients and healthcare providers prefer wearable and wireless cardiac monitoring devices that allow real-time data tracking and reduce hospital visits. Furthermore, rapid technological advancements and continuous product development initiatives by key market players, such as the integration of artificial intelligence, cloud connectivity, miniaturized wearable devices, and improved battery life, are enhancing device accuracy, convenience, and clinical outcomes, thereby supporting overall market expansion.
- The leading companies operating in the cardiac monitoring devices market include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE Healthcare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., Osypka Medical, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Mindray, Dragerwerk AG & CO. KGaA, Lepu Medical Technologies, Fukuda Denshi Co., Ltd., and others.
- North America is expected to dominate the cardiac monitoring devices market, primarily driven by the increasing prevalence of cardiovascular diseases and associated risk factors such as hypertension, obesity, and diabetes. Additionally, the growing demand for remote patient monitoring solutions supported by the rising adoption of telehealth and home-based care is further accelerating market growth in the region. Furthermore, continuous technological advancements and strengthened product development initiatives by key market players are contributing to the introduction of innovative, accurate, and user-friendly cardiac monitoring devices, thereby reinforcing North America’s leading position in the market.
- In the product type segment of the cardiac monitoring devices market, within the ECG devices segment, the Holter monitors category is estimated to account for the largest market share in 2025.
- Increasing prevalence of cardiovascular diseases and related risk factors is escalating the overall market of cardiac monitoring devices: The increasing prevalence of cardiovascular diseases (CVDs) and associated risk factors is a major driver of growth in the cardiac monitoring devices market. Conditions such as heart failure, coronary artery disease, arrhythmias, and hypertension are becoming more common due to aging populations, sedentary lifestyles, unhealthy diets, obesity, diabetes, and high stress levels. As the number of patients at risk of heart-related complications continues to rise, there is a growing need for continuous and accurate heart monitoring to enable early detection, timely intervention, and effective disease management. Cardiac monitoring devices, including wearable monitors, Holter monitors, implantable loop recorders, and remote monitoring systems, play a crucial role in tracking heart rhythms and identifying abnormalities before they become severe. Therefore, the rising burden of cardiovascular diseases and related lifestyle risk factors is significantly increasing the demand for advanced cardiac monitoring solutions across healthcare settings.
- Increasing demand for remote patient monitoring leading to a surge in cardiac monitoring devices: The increasing demand for remote patient monitoring (RPM) is significantly driving the surge in cardiac monitoring devices, as healthcare systems shift toward continuous, home-based care and early disease detection. Rising prevalence of cardiovascular diseases, growing elderly populations, and the need to reduce hospital visits have accelerated the adoption of wearable ECG monitors, Holter monitors, patch-based monitors, and implantable loop recorders. Remote monitoring enables real-time data transmission to physicians, allowing timely intervention, improved patient outcomes, and reduced readmission rates. As telehealth infrastructure expands and digital health integration improves, demand for advanced cardiac monitoring devices continues to grow rapidly.
- Rising technological advancements and enhanced product development initiatives by key market players: Rising technological advancements and strengthened product development initiatives by key market players are significantly driving growth in the cardiac monitoring devices market. Leading companies are increasingly investing in research and development to introduce advanced, accurate, and user-friendly monitoring solutions. Innovations such as wearable ECG monitors, wireless and patch-based devices, AI-enabled analytics, and cloud-connected remote monitoring systems are improving early detection and continuous tracking of cardiac conditions. Additionally, companies are focusing on miniaturization, longer battery life, real-time data transmission, and improved patient comfort, making devices more suitable for both clinical and home settings. These continuous advancements and new product launches are enhancing diagnostic efficiency, supporting personalized cardiac care, and expanding the overall adoption of cardiac monitoring technologies.
This cardiac monitoring devices market report offers a comprehensive overview of the global cardiac monitoring devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (ECG Devices {Holter Monitors, Resting ECG, and Stress ECG}, Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-Users (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cardiac monitoring devices market.
Cardiac monitoring devices are medical devices used to continuously or intermittently measure and record the electrical activity and overall function of the heart. These devices help detect, diagnose, and manage heart-related conditions such as arrhythmias, heart failure, myocardial infarction, and other cardiovascular disorders.
The cardiac monitoring devices market is primarily driven by the increasing prevalence of cardiovascular diseases and associated risk factors such as hypertension, obesity, and diabetes. Additionally, the growing demand for remote patient monitoring solutions, especially with the rise of home-based care and telehealth services, is significantly supporting market growth. Furthermore, continuous technological advancements and increased product development initiatives by key market players are enhancing device accuracy, portability, and connectivity, thereby accelerating overall market expansion.
Get More Insights into the Report @Cardiac Monitoring Devices Market
What are the latest cardiac monitoring devices market dynamics and trends?
The cardiac monitoring devices market is experiencing significant growth, primarily fueled by the increasing incidence of cardiovascular diseases (CVDs), including heart failure and coronary artery disease, as well as the growing burden of related risk factors.
According to the Institute for Health Metrics and Evaluation (2025), ischemic heart disease affected an estimated 240 million people in 2023 worldwide. As ischemic heart disease results from reduced blood supply to the heart caused by coronary artery narrowing, patients require continuous and long-term cardiac surveillance to detect ischemic episodes, rhythm abnormalities, and recurrent cardiac events at an early stage. This has increased the demand for advanced monitoring technologies, including ECG systems, Holter monitors, wearable ECG patches, telemetry systems, and implantable loop recorders.
Additionally, the increase in cases of associated risk factors such as hypertension, obesity, and diabetes is further boosting the overall market of cardiac monitoring devices. According to the data provided by the World Health Organization (2025), approximately 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. Obesity is significantly boosting the overall market of cardiac monitoring devices because it is a major risk factor for several cardiovascular conditions, including Coronary Artery Disease, Atrial Fibrillation, Heart Failure, and Hypertension. Excess body weight contributes to structural and electrical remodeling of the heart, increasing the likelihood of arrhythmias and ischemic events that require continuous cardiac rhythm assessment. As obesity prevalence rises globally, the number of high-risk patients needing early detection, long-term ECG tracking, and post-treatment surveillance also increases, thereby boosting the overall market of cardiac monitoring devices across the world.
Moreover, wearable and remote patient monitoring technologies are significantly accelerating growth in the cardiac monitoring devices market by enabling continuous, convenient, and real-time tracking of heart health outside hospital settings, improving early detection of arrhythmias, ischemia, and other cardiac events while reducing the need for in-person visits and supporting telehealth care delivery. This shift toward decentralized care and preventive cardiology has increased demand for smart wearables, ECG patches, mobile telemetry systems, and cloud-linked monitoring platforms that transmit data directly to clinicians for timely intervention, driving broader market adoption and innovation. Specifically, recent approvals and product launches include: in July 2025, the FDA cleared the CardioTag wearable capable of capturing ECG, photoplethysmogram (PPG), and seismocardiogram (SCG) signals, enhancing non-invasive cardiac insights.
However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For instance, in June 2024, Endotronix received U.S. FDA Premarket Approval (PMA) for its Cordella PA Sensor System, designed to manage patients with NYHA Class III heart failure. The system enables remote monitoring of pulmonary artery pressure along with non-invasive vital signs, helping clinicians optimize treatment plans and reduce the risk of hospitalizations. The company anticipated a U.S. commercial launch later in the year, while CE mark review was underway to support expansion into the European market.
Overall, the rising prevalence of cardiovascular diseases, the growing adoption of remote monitoring solutions, and continuous regulatory approvals are collectively expected to strongly propel the growth of the global cardiac monitoring devices market throughout the forecast period.
Moreover, the cardiac monitoring devices market faces several restraints and challenges. One major concern is data privacy and security, as these devices collect and store sensitive patient health information, which can be vulnerable to cyberattacks and data breaches. Additionally, limitations associated with the devices, such as high costs, limited battery life, technical errors, and the need for regular maintenance, can restrict their widespread adoption. Furthermore, issues related to device accuracy, connectivity problems, and a lack of skilled professionals to interpret complex data may also hinder market growth.
Cardiac Monitoring Devices Market Segment Analysis
Cardiac Monitoring Devices Market by Product Type (ECG Devices {Holter Monitors, Resting ECG, and Stress ECG}, Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-Users (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Cardiac Monitoring Devices Market Regional Analysis
North America Cardiac Monitoring Devices Market Trends
North America is expected to account for the highest proportion of 41% of the cardiac monitoring devices market in 2025, out of all regions. North America is expected to hold the largest share of the global cardiac monitoring devices market, primarily supported by the high incidence of cardiovascular diseases, a growing geriatric population, and the early adoption of advanced technologies, including AI-enabled wearables and remote patient monitoring systems. The region benefits from a well-established healthcare infrastructure, favorable reimbursement policies, and consistent FDA approvals for innovative cardiac devices, all of which strengthen its market dominance. Furthermore, the strong presence of leading industry players and an increasing focus on preventive and value-based healthcare continue to drive sustained market growth across the region.
According to the Centers for Disease Control and Prevention (2024), it was estimated that approximately 12.1 million people in the United States would have atrial fibrillation (AFib) by 2050. Additionally, according to DelveInsight’s 2024 analysis, an estimated 5.0% of adults in the United States had coronary heart disease. Both conditions are significant contributors to heart failure and other serious complications, highlighting the urgent need for effective cardiac monitoring solutions that support early diagnosis, better disease management, and improved survival rates.
Additionally, awareness campaigns such as American Heart Month, spearheaded by organizations like the American Heart Association (AHA) and the CDC, play an important role in encouraging prevention, routine screenings, and continuous heart health monitoring. These initiatives, combined with ongoing product innovations, are further accelerating the adoption of advanced cardiac monitoring devices.
However, the increase in product development activities is further boosting the overall market ofcardiac monitoring devices. For example, in November 2024, Fourth Frontier received U.S. FDA 510(k) clearance for its Frontier X Plus, a single-lead continuous ECG monitor designed to be worn around the chest. The device wirelessly transmits ECG data to remote monitoring dashboards and uses advanced algorithms to detect and classify cardiac rhythms, including bradycardia, tachycardia, normal sinus rhythm, and atrial fibrillation.
Overall, the substantial burden of cardiovascular diseases, rapid adoption of advanced technologies, growing patient awareness, and a consistent flow of regulatory approvals are collectively expected to support the sustained growth of the cardiac monitoring devices market across North America.
Thus, all the above-mentioned factors are anticipated to propel the market for cardiac monitoring devices in North America during the forecast period.
Europe Cardiac Monitoring Devices Market Trends
Europe is contributing significantly to the expansion of the cardiac monitoring devices market, supported by the increasing prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and favorable regulatory and reimbursement policies.
According to DelveInsight’s 2023 analysis of the EU4 and the UK, the prevalence of diagnosed atherosclerotic cardiovascular disease (ASCVD) was notably higher in males, with approximately 12,601 thousand cases, compared to around 8,645 thousand cases in females. Men generally develop ASCVD at an earlier age and face a greater risk of coronary heart disease (CHD) than women. This substantial burden of heart and circulatory disorders has significantly increased the demand for advanced diagnostic and monitoring technologies, including Holter monitors, implantable loop recorders, telemetry systems, and wearable ECG devices.
Furthermore, healthcare providers across Europe are progressively adopting remote patient monitoring and digital health solutions, supported by initiatives aimed at strengthening telemedicine services and reducing hospital readmissions. However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For example, in January 2024, iRhythm Technologies received CE Mark certification under the new EU Medical Device Regulation (MDR) for its next-generation Zio ECG monitoring system and the ZEUS AI-powered ECG analysis platform, marking a key milestone in ambulatory cardiac monitoring innovation. With increasing investments in AI-enabled monitoring systems, wearable technologies, and cross-border healthcare advancements, Europe continues to play a critical role in driving the growth and evolution of the cardiac monitoring devices market.
Hence, all the factors mentioned above are expected to drive the market for cardiac monitoring devices in Europe during the forecast period.
Asia-Pacific Cardiac Monitoring Devices Market Trends
The Asia-Pacific region is increasingly becoming a key growth engine for the cardiac monitoring devices market, supported by the rising incidence of cardiovascular diseases, a rapidly expanding elderly population, and the growing adoption of digital healthcare technologies. Major countries such as China, India, and Japan are witnessing a significant increase in heart-related disorders, largely driven by lifestyle changes, rapid urbanization, and the escalating prevalence of risk factors including diabetes, obesity, and hypertension.
According to an article published in the European Heart Journal in 2025, cardiovascular diseases affected approximately 341.6 million people across the Asia-Pacific region, with a 95% uncertainty interval (UI) ranging from 301.9 million to 329.1 million. The increasing prevalence of cardiovascular diseases (CVDs) is a major factor driving the growth of the cardiac monitoring devices market. As conditions such as coronary artery disease, heart failure, atrial fibrillation, and hypertension become more widespread, the need for continuous and accurate heart monitoring has grown significantly. Since many heart disorders require early detection and long-term management to prevent serious complications, demand for devices such as ECG systems, Holter monitors, implantable loop recorders, and wearable monitors continues to rise. Overall, the growing global burden of CVDs is strongly accelerating the adoption and development of advanced cardiac monitoring technologies.
Governments and healthcare providers across the region are making substantial investments in upgrading healthcare infrastructure and expanding remote patient monitoring programs to enhance access to cardiac care, particularly in rural and underserved areas. At the same time, the growing adoption of wearable and portable cardiac monitoring devices, along with the strategic expansion efforts of global companies into emerging Asian markets, is further supporting regional market growth.
However, the increase in product development activities is further boosting the overall market of cardiac monitoring devices. For example, in May 2025, iRhythm Technologies introduced its Zio® long-term continuous ECG monitoring (LTCM) system in Japan. The system offers up to 14 days of uninterrupted ECG monitoring and incorporates deep-learning AI algorithms approved by Japan’s PMDA, representing a significant advancement over traditional Holter monitoring solutions.
Thus, the factors mentioned above are expected to boost the market of cardiac monitoring devices across the Asia-Pacific region.
Who are the major players in the cardiac monitoring devices market?
The following are the leading companies in the cardiac monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.
- Boston Scientific Corporation
- Neurosoft
- ACSDiagnostics
- Medtronic
- Biotronik
- Abbott
- Koninklijke Philips NV
- GE Healthcare
- AliveCor Inc.
- ZOLL Medical Corporation
- Bexen Cardio
- iRhythm Technologies, Inc
- OSYPKA MEDICAL
- Nihon Kohden Corporation
- BPL Medical Technologies
- Schiller AG
- Mindray
- Drägerwerk AG & Co. KGaA,
- Lepu Medical Technologies
- Fukuda Denshi Co., Ltd
- Others
The competitive landscape of the cardiac monitoring devices market is becoming increasingly dynamic and innovation-driven. Leading medical device companies are focusing heavily on technological advancements such as wireless connectivity, artificial intelligence (AI)–based arrhythmia detection, cloud integration, and wearable monitoring solutions to strengthen their market position. Continuous product development and frequent product launches are enabling companies to offer more accurate, portable, and patient-friendly devices, which is intensifying competition across both hospital and home-care segments. In addition, strategic partnerships, mergers and acquisitions, and collaborations with digital health and telemedicine providers are reshaping the market structure. Established players are expanding their product portfolios, while emerging companies and startups are entering the market with innovative wearable and remote monitoring technologies. The growing demand for remote patient monitoring and long-term cardiac care has further accelerated competition, pushing companies to differentiate themselves through improved data analytics, longer monitoring durations, and better user experience. Overall, the market is characterized by strong competition, rapid technological evolution, and increasing investment in research and development, all of which are contributing to continuous innovation and market growth.
Recent Developmental Activities in the Cardiac Monitoring Devices Market
- In July 2025, the U.S. Food and Drug Administration (FDA) granted clearance to the CardioTag device, marking it as the first wearable technology capable of simultaneously capturing electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals
- In March 2025, Sibel Health received its seventh U.S. FDA 510(k) clearance for the ANNE One wireless monitoring platform. The system is designed to continuously capture comprehensive vital signs for patients aged 12 years and older, including ECG, heart rate, respiratory rate, and additional physiological parameters.
- In March 2025, at HIMSS, Peerbridge Health unveiled the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias and offering features like 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
- In May 2025, iRhythm launched its Zio® long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan’s PMDA. This provides a significant step-up from traditional Holter monitors.
- Cardiac Monitoring Devices by Product Type Exposure
- Holter Monitors
- Resting ECG
- Stress ECG
Event Recorders
Echocardiogram
Mobile Cardiac Telemetry
Others
- Cardiac Monitoring Devices End-Users Exposure
Ambulatory Surgical Centers
Homecare Settings
Others
- Cardiac Monitoring Devices Geography Exposure
- United States Cardiac Monitoring Devices Market
- Canada Cardiac Monitoring Devices Market
- Mexico Cardiac Monitoring Devices Market
- United Kingdom Cardiac Monitoring Devices Market
- Germany Cardiac Monitoring Devices Market
- France Cardiac Monitoring Devices Market
- Italy Cardiac Monitoring Devices Market
- Spain Cardiac Monitoring Devices Market
- Rest of Europe Cardiac Monitoring Devices Market
- China Cardiac Monitoring Devices Market
- Japan Cardiac Monitoring Devices Market
- India Cardiac Monitoring Devices Market
- Australia Cardiac Monitoring Devices Market
- South Korea Cardiac Monitoring Devices Market
- Rest of Asia-Pacific Cardiac Monitoring Devices Market
- South America Cardiac Monitoring Devices Market
- Middle East Cardiac Monitoring Devices Market
- Africa Cardiac Monitoring Devices Market
AI-Powered Innovations and Applications:
Artificial intelligence (AI) is significantly transforming the cardiac monitoring devices market by improving diagnostic accuracy, enhancing efficiency, and enabling more proactive patient care. AI-powered algorithms can analyze large volumes of electrocardiogram (ECG) data in real time, allowing faster and more precise detection of arrhythmias, atrial fibrillation, heart failure risk, and other cardiac abnormalities. This reduces the likelihood of missed diagnoses and supports clinicians in making timely, data-driven treatment decisions. One of the major impacts of AI integration is the improvement in early detection and predictive analytics. Advanced machine learning models can identify subtle patterns in heart rhythm data that may not be easily recognized by traditional monitoring methods. This enables earlier intervention, reduces hospital readmissions, and improves long-term patient outcomes. Additionally, AI enhances remote patient monitoring by automatically filtering and prioritizing clinically significant events, reducing the burden on healthcare professionals and minimizing false alarms. AI-powered cardiac monitoring devices also contribute to operational efficiency within healthcare systems. Automated data interpretation shortens analysis time, streamlines workflow, and allows cardiologists to focus on critical cases. In wearable and ambulatory monitoring devices, AI supports continuous data tracking and real-time alerts, improving patient engagement and enabling personalized care management.
U.S. Tariff Impact Analysis on Cardiac Monitoring Devices Market:
U.S. tariffs on imported electronic components and medical device parts have had a moderate impact on the cardiac monitoring devices market. Since many cardiac monitoring systems, such as ECG machines, Holter monitors, and wearable cardiac patches, rely on imported semiconductors, sensors, and other electronic components, increased tariffs can raise manufacturing and procurement costs. This may lead to higher device prices for hospitals and healthcare providers.
In response, manufacturers are adjusting their supply chains by diversifying sourcing strategies, increasing domestic production, or negotiating long-term supplier contracts to reduce cost pressures. While large established companies are better positioned to absorb these added costs, smaller manufacturers may face tighter margins. Overall, tariffs have contributed to pricing and supply chain challenges but have also encouraged supply chain resilience and local manufacturing investments within the U.S. market.
How This Analysis Helps Clients
- Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
- Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
- Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
- Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
- Market size analysis for the current cardiac monitoring devices market size (2025), and market forecast for 8 years (2026 to 2034)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the cardiac monitoring devices market.
- Various opportunities available for the other competitors in the cardiac monitoring devices market space.
- What are the top-performing segments in 2025? How these segments will perform in 2034?
- Which are the top-performing regions and countries in the current cardiac monitoring devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the cardiac monitoring devices market growth in the future?
Table of Contents
150 Pages
- 1. Cardiac Monitoring Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Cardiac Monitoring Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Cardiac Monitoring Devices Market Key Factors Analysis
- 3.1 Cardiac Monitoring Devices Market Drivers
- 3.1.1 The increasing prevalence of cardiovascular diseases and related risk factors
- 3.1.2 Increasing demand for remote patient monitoring
- 3.1.3 Rising technological advancements and enhanced product development initiatives by key market players
- 3.2 Cardiac Monitoring Devices Market Restraints and Challenges
- 3.2.1 Data privacy and security
- 3.2.2 Limitations associated with the devices, such as motion artifacts, battery storage, and others
- 3.3 Cardiac Monitoring Devices Market Opportunity
- 3.3.1 Integration of AI and machine learning for the interpretation of cardiac data
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Cardiac Monitoring Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Cardiac Monitoring Devices Market Assessment
- 7.1 By Product Type
- 7.1.1 ECG Devices
- 7.1.1.1 Holter Monitors
- 7.1.1.2 Resting ECG
- 7.1.1.3 Stress ECG
- 7.1.2 Implantable Loop Recorders
- 7.1.3 Event Recorders
- 7.1.4 Echocardiogram
- 7.1.5 Mobile Cardiac Telemetry
- 7.1.6 Others
- 7.2 By End-Users
- 7.2.1 Hospitals
- 7.2.2 Ambulatory Surgical Centers
- 7.2.3 Homecare Settings
- 7.2.4 Others
- 7.3 By Geography
- 7.3.1 North America
- 7.3.1.1 United States Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.1.2 Canada Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.1.3 Mexico Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2 Europe
- 7.3.2.1 France Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.2 Germany Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.3 United Kingdom Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.4 Italy Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.5 Spain Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.6 Rest of Europe Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3 Asia-Pacific
- 7.3.3.1 China Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.2 Japan Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.3 India Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.4 Australia Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.5 South Korea Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.6 Rest of Asia-Pacific Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4 Rest of the World (RoW)
- 7.3.4.1 Middle East Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4.2 Africa Cardiac Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4.3 South America Cardiac Monitoring Devices Market Size In USD Million (2023-2034)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Cardiac Monitoring Devices Market Company and Product Profiles
- 10.1 Medtronic
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Boston Scientific Corporation
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Neurosoft
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 ACS Diagnostics
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 Biotronik
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Abbott
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Koninklijke Philips NV
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 GE Healthcare
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 AliveCor Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 ZOLL Medical Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Bexen Cardio
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 iRhythm Technologies Inc.
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 Osypka Medical
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Nihon Kohden Corporation
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 BPL Technologies
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 Schiller AG
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 Mindray
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 Dragerwerk AG & CO. KGaA
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 10.19 Lepu Medical Technologies
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
- 10.20 Fukuda Denshi Co., Ltd.
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
